Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LGALS8 | O00214 | 2/20 | 0.47 |
| ▸ | MGAM | O43451 | 4/20 | 0.44 |
| ▸ | SI | P14410 | 4/20 | 0.44 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
| ▸ | G6PD | P11413 | 1/20 | 0.40 |
| ▸ | PYGB | P11216 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18232569 | 1.00 | LGALS8 (0.47) | LGALS8MGAMSIGAAL3MBTL1 | |
| SCHEMBL14408063 | 1.00 | LGALS8 (0.47) | LGALS8MGAMSIGAAL3MBTL1 | |
| SCHEMBL13148198 | 1.00 | LGALS8 (0.47) | LGALS8MGAMSIGAAL3MBTL1 | |
| SCHEMBL13779601 | 1.00 | LGALS8 (0.47) | LGALS8MGAMSIGAAL3MBTL1 | |
| SCHEMBL4570715 | 1.00 | LGALS8 (0.47) | LGALS8MGAMSIGAAL3MBTL1 | |
| SCHEMBL17464420 | 1.00 | LGALS8 (0.47) | LGALS8MGAMSIGAAL3MBTL1 | |
| SCHEMBL18349325 | 1.00 | LGALS8 (0.47) | LGALS8MGAMSIGAAL3MBTL1 | |
| SCHEMBL22058805 | 1.00 | LGALS8 (0.47) | LGALS8MGAMSIGAAL3MBTL1 | |
| SCHEMBL20798403 | 1.00 | LGALS8 (0.47) | LGALS8MGAMSIGAAL3MBTL1 | |
| SCHEMBL12082884 | 1.00 | LGALS8 (0.47) | LGALS8MGAMSIGAAL3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 92 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230399494-A1 | COMPOSITION COMPRISING A HIGHLY SUBSTITUTED HYDROXYPROPYL METHYLCELLULOSE AND A SUGAR ALCOHOL | DDP SPECIALTY ELECTRONIC MATERIALS US, LLC | 2023-12-14 | — | — | US | disclosed |
| US-20230302430-A1 | SELENIOUS ACID ADSORBENT | NATIONAL UNIVERSITY CORPORATION KANAZAWA UNIVERSITY (JP) | 2023-09-28 | — | — | US | disclosed |
| US-20230278007-A1 | CELLULOSE DERIVATIVE AND METAL ADSORBENT CONTAINING SAID CELLULOSE DERIVATIVE | NATIONAL UNIVERSITY CORPORATION KANAZAWA UNIVERSITY (JP) | 2023-09-07 | — | — | US | disclosed |
| WO-2023083654-A1 | FEED COMPOSITION AND USES THEREOF | GIVAUDAN SA (CH) | 2023-05-19 | — | — | WO | disclosed |
| US-20230022614-A1 | POLYMERIC FATTY ACID SALT COMPOUNDS FOR THE TREATMENT OF FIBROUS AMINO ACID-BASED SUBSTRATES, ESPECIALLY HAIR | MOMENTIVE PERFORMANCE MAT GMBH (DE) | 2023-01-26 | — | — | US | disclosed |
| US-20210371390-A1 | AMYLOID TARGETING AGENTS AND METHODS OF USING THE SAME | Amydis, Inc. | 2021-12-02 | — | — | US | disclosed |
| EP-3433422-B1 | POLYSACCHARIDE DERIVATIVES AS OPTICAL BRIGHTENING AGENTS | AABO AKADEMI UNIV (FI) | 2020-11-18 | — | — | EP | disclosed |
| EP-3137573-B1 | NEW CHROMOPHORIC STRUCTURES FOR LANTHANIDE CHELATES FIELD OF THE INVENTION | RADIOMETER TURKU OY (FI) | 2018-08-01 | — | — | EP | disclosed |
| US-9982393-B2 | Chitosan as a biobased barrier coating for functional paperboard products | WESTERN MICHIGAN UNIVERSITY RESEARCH FOUNDATION (US) | 2018-05-29 | — | — | US | disclosed |
| US-9962446-B2 | Solid dispersion comprising a highly substituted hydroxyalkyl methylcellulose | DOW GLOBAL TECHNOLOGIES LLC (US) | 2018-05-08 | — | — | US | disclosed |
| US-20090264639-A1 | Polysaccharide derivative and separating agent for optical isomer containing the same | NATIONAL UNIVERSITY CORPORATION NAGOYA UNIVERSITY (JP) | 2009-10-22 | — | — | US | disclosed |
| US-20090068468-A1 | Bead for Enantiomeric Isomer Resolution and Process for Producing the Same | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 2009-03-12 | — | — | US | disclosed |
| US-20090062123-A1 | Glyphosate composition and method of controlling weeds | NUFARM AMERICAS, INC (US) | 2009-03-05 | — | — | US | disclosed |
| EP-1520583-B1 | NKT cell-activating agents containing alpha-glycosylceramides | KYOWA HAKKO KIRIN CO LTD (JP) | 2009-01-28 | — | — | EP | disclosed |
| US-20080262107-A1 | A solid amorphous dispersion of a low-soluble drug and hydroxypropylmethyl celllulose acetate succinate with an ester degree of substitution of 0.85 which results in concentration-enhancement, time release agents, and storage stability; rapid crystal growth inhibitors in supersaturated aqueous solutions | PFIZER PRODUCTS INC. (US) | 2008-10-23 | — | — | US | disclosed |
| US-7354982-B2 | Saccaride residue-functional organopolysiloxanes and method for the preparation thereof | DOW CORNING TORAY SILICONE CO., LTD. (JP) | 2008-04-08 | — | — | US | disclosed |
| US-20080064763-A1 | solid amorphous dispersions of low-solubility drugs and hydroxypropyl methyl cellulose alkanyl phthalate; enhance physical stability, absorption of drug in vivo, drug's bioavailability; fluvastatin HMG-CoA reductase inhibitor | BEND RESEARCH, INC. | 2008-03-13 | — | — | US | disclosed |
| US-20070243152-A1 | Formula for fabricating skin treatment product and forming method thereof | WANG, CHIEN-CHANG (TW) | 2007-10-18 | — | — | US | disclosed |
| US-20070117971-A1 | Cellulose based optical film material and method for forming the same | NATIONAL TAIWAN NORMAL UNIVERSITY (TW) | 2007-05-24 | — | — | US | disclosed |
| US-7208561-B2 | Saccharide residue-functional organopolysiloxanes and method for the preparation thereof | DOW CORNING TORAY SILICONE, CO. LTD. (JP) | 2007-04-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (9 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080064763-A1 | solid amorphous dispersions of low-solubility drugs and hydroxypropyl methyl cellulose alkanyl phthalate; enhance physical stability, absorption of drug in vivo, drug's bioavailability; fluvastatin HMG-CoA reductase inhibitor | HMGCR, CYP3A43, CYP4F3 | LGALS8 3107/4885MGAM 420/4885SI 18/4885 |
| US-20070243152-A1 | Formula for fabricating skin treatment product and forming method thereof | MGAM, CUTA, ENGASE | LGALS8 199/4885MGAM 1/4885SI 40/4885 |
| US-20090068468-A1 | Bead for Enantiomeric Isomer Resolution and Process for Producing the Same | AGL, F7, ALG1 | LGALS8 2456/4885MGAM 118/4885SI 40/4885 |
| US-20210371390-A1 | AMYLOID TARGETING AGENTS AND METHODS OF USING THE SAME | APP, CRYAA, APBA1 | LGALS8 495/4885MGAM 435/4885SI 1927/4885 |
| US-20070117971-A1 | Cellulose based optical film material and method for forming the same | PLCB3, PLCG2, PHOSPHO1 | LGALS8 2503/4885MGAM 79/4885SI 677/4885 |
| US-20090264639-A1 | Polysaccharide derivative and separating agent for optical isomer containing the same | FUT5, FUT6, DDOST | LGALS8 114/4885MGAM 23/4885SI 42/4885 |
| US-20230022614-A1 | POLYMERIC FATTY ACID SALT COMPOUNDS FOR THE TREATMENT OF FIBROUS AMINO ACID-BASED SUBSTRATES, ESPECIALLY HAIR | DAO, ELOVL3, ELOVL6 | LGALS8 3236/4885MGAM 2634/4885SI 822/4885 |
| US-20080262107-A1 | A solid amorphous dispersion of a low-soluble drug and hydroxypropylmethyl celllulose acetate succinate with an ester degree of substitution of 0.85 which results in concentration-enhancement, time release agents, and storage stability; rapid crystal growth inhibitors in supersaturated aqueous solutions | HPD, HAAO, SUCLA2 | LGALS8 2915/4885MGAM 4/4885SI 15/4885 |
| US-20090062123-A1 | Glyphosate composition and method of controlling weeds | AGXT, PHYKPL, GRIK3 | LGALS8 3211/4885MGAM 133/4885SI 534/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.